Celebrate Sarcoma Awareness Month with Renowned Cancer Treatment Center

Sarcoma is a rare kind of cancer. Sarcomas are different from the carcinomas as they grow in the different tissue. Sarcoma is cancer that grows mainly in cells that support other tissues in the body. The sarcomas are grouped in two groups soft tissue sarcoma and osteosarcoma for easy classification.

Santa Monica, CA -- (SBWire) -- 07/29/2015 --Know About New Treatment For Ewing's Sarcoma With renowned Cancer Treatment Center

The month of July is celebrated as the Sarcoma awareness month. The month is celebrated to create awareness about cancer that accounts for 1% cancer in adults while constitutes 15% of cancer in children. Dr. Robert Maki-chairperson of the Sarcoma Program and Pediatric Hematology-Oncology at Mount Shinai Hospital states "Sarcoma is nature's proof that cancer can grow anywhere in the whole body from scalp to toes". The chairperson further defines the sarcoma as cancer that arises from the stuff that holds humans together, be it bone, cartilage or muscle". The sarcomas are most popular among the children. Therefore, a treatment is evolved to medicate children who suffer from a lethal pediatric tumor bone and soft tissue called Ewing's sarcoma.

The researchers of Virgen del Rocio hospital in Seville, Sant Joan de Deu and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona has combined the two active ingredients for treatment of Ewing's sarcoma. The combination of the two ingredients Olaparib and Trabectedin were experimented in an animal model. The results of the experiment show that the combination destroys the cancerous cells that multiplies and spreads. In fact, the researchers have observed the remission of the cancerous cells in 100% of cases for a very long period of time. The results are also published in a journal Oncotarget.

Ewing's sarcoma is second most common cancer in the youth and children. Cancer originates in the bone cells. The other way cancer can spread is through a process called metastasis. Cancer that occurs from the process called metastasis is called secondary cancer. At the Renowned cancer treatment center, an individual finds the newest innovated technology for the treatment of Ewing's sarcoma.

The spread of the Ewing's sarcoma mainly depends on the capability of the cancerous cells to repair the mechanisms of the damaging DNA in good condition to survive and divide. The ingredient- Trabectedin used at the renowned cancer treatment center for the treatment of Ewing's sarcoma breaks the DNA of the cancerous cell, which includes the death of the cell. The another ingredient- Olaparib of the combination blocks the working of the (PARP1). The gene accelerates the rate of the repair of DNA of the cancerous cell. Therefore, the combination of Olaparib and Trabectedin practically kills the cells that are responsible for the spread of Ewing's sarcoma.

The combination is synergistic and can eliminate all the cancerous tissues from the body of an affected individual. One of the ingredients-Olaparib is FDA approved for the targeted therapy of cancer. The ingredient is also useful for the treatment of some ovarian, breast and prostate cancer. The other ingredient Trabectedin is an anti-tumor drug. It is also used for the medication of the ovarian cancers.

About The Sarcoma Oncology Center
The Sarcoma Oncology Center employs a team of the board certified practitioners in internal medicine, hematology and medical oncology. The research regarding the new techniques to fight against the cancer are also made at the center.

To book an appointment for a consultation please call 310-552-9999 or visit http://www.sarcomaoncology.com

Media Relations Contact

The Manager
310-879-1106
http://sarcomaoncology.com/

View this press release online at: http://rwire.com/613867